It is a ganglion blocking agent as it is a nicotinic receptor antagonist at the neuromuscular junction.
It is also a potent medium-acting muscle relaxant and hypotensive belonging to the family of non depolarizing myorelaxant. It is an antagonist of Proserine, Galanthamine.

It has a good penetration of the blood-tissue barrier. It acts on nicotinic cholinoreceptors of the Peripheral and Central Nervous Systems, whatever the way of administering in vivo.
On cat under anaesthesia, 1.5 mg/kg (i.v.) or 30 mg/kg (p.o.) block the activity of N-cholinoreceptors at the neuromuscular junction. 10^-5 g/ml block the neuromuscular transmission on the rat diaphragm preparation.
0.5-2 mg/kg (i.v.) on cat under anaesthesia, cause hypotension due to the blockade of the transmission of nervous impulses in sympathetic and orthosympathetic ganglia.

Stable in dry state, store at + 4°C, in dark place.
Solution for experiments in vitro: 10^-5 - 10^-7 M.
Doses for experiments in vivo on cats and dogs: 1-3 mg/kg (i.v.) or 20-30 mg/kg (p.o.).

For research use only — not intended for food, diagnostic or therapeutic use